Europlasma extends negotiations to sell its defense activities

Europlasma, a strategic industrial group, has announced the extension of the negotiation period for the sale of its defense division. Initially scheduled to end on May 25, 2026, the period has been extended by one month. This division includes the production of hollow bodies for large-caliber shells.

The group emphasizes that any final decision remains subject to applicable regulations, including consultation with employee representatives. Europlasma is committed to informing the market of any significant developments.

This transaction is part of a broader financing and development strategy, supported by the Environmental Performance Financing fund. The consequences of the bond-to-equity conversion remain a factor for investors to monitor.